Glycine antagonist (GV150526) in acute stroke: A multicentre, double-blind placebo-controlled phase II trial

Cunha, L., Diener, H., Lavelle, J., Lees, K., Sanders, E., Tack, P. and Wester, P. (2001) Glycine antagonist (GV150526) in acute stroke: A multicentre, double-blind placebo-controlled phase II trial. Cerebrovascular Diseases, 11, pp. 20-29.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Lees, Professor Kennedy
Authors: Cunha, L., Diener, H., Lavelle, J., Lees, K., Sanders, E., Tack, P., and Wester, P.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences
Journal Name:Cerebrovascular Diseases

University Staff: Request a correction | Enlighten Editors: Update this record